SLDB Solid Biosciences LLC
Company Analysis
Latest News
🔴 Solid Biosciences is trading 5.37% down in pre-market
Solid Biosciences is trading 5.37% down at $8.10 in pre-market, with no new company-specific announcement identified for August 11, 2026. - The August 6...
🟢 Solid Biosciences is trading 8.6% up in pre-market after smaller-than-expected loss
Solid Biosciences is trading 8.6% up at $9.30 amid continued investor response to its August 6 earnings release, including a smaller-than-expected loss and...
Solid Biosciences Jumps 13% on Earnings Beat and Safety Data — But Can a Pre-Revenue Gene Therapy Firm Close the Gap to Its $17 Price Target?
Shares shifted sharply higher as Solid Biosciences delivered a one-two punch: a smaller-than-expected quarterly loss and reassuring safety data for its lead...
🟢 Solid Biosciences is trading 13.11% up in pre-market after beating Q2 EPS estimates
Solid Biosciences is trading 13.11% up at $9.49 after investors continued reacting to its August 6, 2026, second-quarter report and pipeline update. • Q2 EPS...
Solid Biosciences LLC Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Consensus analyst expectations for Solid Biosciences LLC point to second-quarter revenue of $0.00 and an EPS loss of $0.43, while the stock currently trades...
🔴 Solid Biosciences is trading 6.4% down in pre-market after Q2 2026 results as net loss widens
Solid Biosciences is trading 6.4% down now at $8.15 after releasing second-quarter results after the August 6 session, with investors appearing focused on...
🔴 Solid Biosciences is trading 5.28% down in after-hours trading after releasing Q2 2026 financial results
Solid Biosciences is trading 5.28% down at $8.25 in after-hours trading after releasing second-quarter 2026 financial results after the August 6 session. -...
🟢 Solid Biosciences is trading 6% up today amid broad biotech sector strength
Solid Biosciences is trading 6% higher at $8.50 today as the stock benefits from a broadly positive backdrop for the biotech sector and U.S. equities. • The...
🔴 Solid Biosciences is trading 5.2% down today amid a broad biotech pullback and profit-taking
Solid Biosciences is trading 5.2% down today at $8.05 as the stock gives back recent gains in tandem with a broader retreat across the biotechnology sector. •...
🟢 Solid Biosciences is trading 5% up today amid a broader biotech and market rally
Solid Biosciences is trading 5% up today at $8.45 amid a broader rally in the biotech sector and equity markets. • The stock is extending its recent upward...
🔴 Solid Biosciences is trading 5.1% down today amid broader biotech sector weakness
Solid Biosciences is trading at $9.13 (down 5.1%) as risk-off sentiment impacts growth stocks and the broader biotech sector. • The move occurs on...
🔴 Solid Biosciences is trading 5.9% down today amid broader biotech sector weakness and risk-off sentiment
Solid Biosciences is trading 5.9% down at $9.75 today, pressured by a broader biotech sector decline and general risk-off sentiment among investors. • The...
🔴 Solid Biosciences is trading 10.2% down
Solid Biosciences is trading at $10.00, down 10.2% from a comparison close of $11.14 during regular trading. This is a price-action follow-up, so a separate...
🔴 Solid Biosciences is trading 7% down today on likely profit-taking after recent gains
Solid Biosciences is trading 7% down at $10.37 today, likely reflecting profit-taking and normal volatility following a strong multi-session rally over the...
🔴 SLDB is trading 5.8% down today on profit-taking after recent rally driven by Russell index additions
• SLDB is trading at $10.50, down 5.8% in pre-market action, easing back after a strong multi-day rally. • The rally, which saw the stock rise roughly 20% over...
🟢 SLDB is trading 5.9% up today with no clear company-specific catalyst
SLDB is trading at 5.9% up now at $10.80 after several days of steady gains and strong technical momentum. Recent data show the stock in a rising short‑term...
🟢 SLDB is trading 5.1% up today amid supportive analyst sentiment and strong-buy consensus
SLDB is trading 5.1% up at $9.95 amid steady recent upside and supportive analyst sentiment. • Shares have climbed over the past week as multiple coverage...
🟢 SLDB is trading 6.4% up today on pipeline optimism and favorable analyst ratings
SLDB is trading at $9.43 (up 6.4%) as investors focus on the company's Duchenne muscular dystrophy gene therapy pipeline and positive analyst outlooks. • The...
🟢 SLDB is trading 5.4% up today as momentum continues from positive Duchenne therapy data
SLDB is trading at $9.27 (+5.40%) as it extends a two-day rally driven by positive clinical data for its experimental Duchenne muscular dystrophy treatment. •...
🟢 SLDB makes sharp 10.2% jump
SLDB is trading at $9.15, up 10.2% versus the comparison close of $8.30 during regular trading. This is a price-movement alert; no separate company-specific...